Luminopia

Cambridge, United States

Luminopia develops a new class of treatments for significant neuro-visual disorders.

$16.0M raised

Jun 2023

Series A

Top Investors

U.S. Venture PartnersMassChallengeShangbay CapitalSony Innovation FundSesame Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Luminopia raised?

Luminopia has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in June 2023.

Who are Luminopia's investors?

Luminopia's investors include U.S. Venture Partners, MassChallenge, Shangbay Capital, Sony Innovation Fund, Sesame Ventures.

Where is Luminopia headquartered?

Luminopia is headquartered in Cambridge, United States.

What does Luminopia do?

Luminopia develops a new class of treatments for significant neuro-visual disorders.

What stage is Luminopia at?

Luminopia is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 27, 2023.

MLA

"Luminopia — Funding & Investors." VCBacked, June 27, 2023, https://www.vcbacked.co/company/luminopia. Accessed June 4, 2026.

APA

VCBacked. (2023). Luminopia — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/luminopia

Wikipedia (cite web)

{{cite web |title=Luminopia — Funding & Investors |url=https://www.vcbacked.co/company/luminopia |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 27, 2023.